ICYMI: Highlights From the 2025 ASPC Congress on CVD Prevention
The meeting included new evidence and expert insights on hormone therapy, AI, and the expanding role of GLP-1 therapies in cardiovascular care.
Read More
Higher BMI, IBD Linked to Hidradenitis Suppurativa Risk via Mendelian Randomization
A study using Mendelian randomization found higher BMI and IBD have causal links to hidradenitis suppurativa risk.
FDA Approves Rucaparib in BRCA-Mutated mCRPC
Rucaparib’s full approval for BRCA-mutated mCRPC is supported by data showing significant gains in radiographic progression-free survival.
Top 5 Most-Read Content From the Center on Health Equity & Access in 2025
Reflect on the challenges in health equity, care access, and policy shifts impacting health insurance and clinical research in 2025.
House Republicans Block Vote on ACA Subsidy Extension
A last-minute push to extend Affordable Care Act subsidies was stopped as GOP leadership prevented an expedited vote, leaving the future of the subsidies uncertain.
Top 5 Most-Read Alopecia Content of 2025
These were the most-read articles on alopecia areata in 2025.
FDA Approves Depemokimab for Severe Eosinophilic Asthma
Twice-yearly depemokimab cuts asthma exacerbations in phase 3 trials for patients aged 12 and older with severe eosinophilic asthma.
Flunomics Report Highlights US Influenza Burden, Vaccine Gaps During 2024-2025 Season: Marco del Riccio, MD
Marco del Riccio, MD, explains that the Flunomics report helped to identify gaps in US vaccine coverage and influenza surveillance during the 2024-2025 season.
Watch
FDA Approves Intranasal Etripamil for Type of Arrhythmia
Intranasal etripamil was approved to self-treat episodes of paroxysmal supraventricular tachycardia, supported by phase 3 RAPID trial data.
Kidney-Safe IBD Treatment: A Guide for Prescribers Treating CKD
Explore safe IBD treatment options for patients with chronic kidney disease, focusing on tailored approaches to optimize kidney health and medication efficacy.
Health-Related Social Needs Linked to Higher ED Use
A new study finds patients with unmet social needs like housing or transportation face higher ED and inpatient use and that resolving these needs may reduce utilization.
ACA Subsidy Expiration Raises Concerns for Behavioral Health Access and ED Strain
With ACA subsidies expiring, experts warn coverage losses could worsen access to behavioral health care and emergency department strains.
Top 5 Most-Read Conference Coverage of 2025
Our top conference coverage of the year highlighted findings presented at CROI 2025, ACCC Spring, and EHA, among others.
Neoadjuvant Immunotherapy Shows Promise in pMMR/MSS Rectal Cancer
High response rates, strong R0 resection, and low severe adverse events with neoadjuvant therapy plus immunotherapy were identified in a rectal cancer study.
ICYMI: Highlights From WCLC 2025
Our top content from the World Conference on Lung Cancer (WCLC) 2025 featured new therapeutic strategies for EGFR+ NSCLC and trial results on amivantamab.
HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances
The past year has seen multiple changes in the HIV space that have long-term effects when it comes to ending the epidemic.
Top 5 Most-Read Chronic Kidney Disease Content of 2025
This year’s most-read articles on CKD highlighted research and insights on drug approvals, guidelines, and value-based care.
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
Today, the FDA issued new guidance allowing de-identified real-world evidence in certain medical device applications, removing a barrier to using large data sources.
FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for Metastatic HER2-Positive Breast Cancer
The FDA approved trastuzumab deruxtecan plus pertuzumab for first-line HER2-positive metastatic breast cancer after DESTINY-Breast09 showed major PFS gains.
DMB-3115 Biosimilar Is Comparable to Ustekinumab in Psoriasis
The ustekinumab biosimilar DMB-3115 matched reference therapy in efficacy and safety for moderate to severe plaque psoriasis, according to a phase 3 trial.
COVID-19 Vaccination in Pregnant Patients Reduces Hospitalization, Preterm Birth Across Variants
COVID-19 vaccination during pregnancy lowers hospitalization and preterm birth risks, providing key guidance for maternal care strategies.
Top 5 Most-Read Breast Cancer Content of 2025
Our top breast cancer stories in 2025 covered FDA approvals, new and failed therapies, screening gaps, and policy factors shaping treatment access and outcomes.
ICYMI: Highlights From AHA 2025 Scientific Sessions
AHA 2025 highlights included new guidelines and targeted approaches advancing heart failure and cardiovascular care.
Pembrolizumab Achieved pCR in Patient With Recurrent DDLPS
The patient was a rare case of a patient with dedifferentiated liposarcoma and a high tumor mutational burden.
Top 5 Most-Read AML Content of 2025
Top articles in 2025 covered advancements in acute myeloid leukemia treatments, including allogeneic CAR T-cell therapy.
Presentation on Menin Inhibitors Strives to Stay Ahead of the Progress
Eunice Wang, MD, highlights breakthroughs in menin inhibitors for acute leukemias, showcasing promising combination therapies and addressing treatment challenges at ASH 2025.
Bispecifics in New Combos, New Uses, and Earlier Lines of Treatment in Myeloma
New research reveals teclistamab and daratumumab significantly enhance progression-free survival in multiple myeloma, reshaping treatment standards.
Study: People With PF Prefer “Blended” Patient Education Approach
Patients with pulmonary fibrosis (PF) obtain much of their information from the internet, a new report finds, even though a significant amount of information on the internet is incomplete or inaccurate.
FDA Approves Once-Monthly PCSK9 Injection for LDL-C Reduction
Lerodalcibep-liga subcutaneous injection is now approved for adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia.
Convolutional Neural Network Improves MS Lesion Segmentation
Developers say more accurate automated multiple sclerosis lesion segmentation can improve research and patient care.
